CRDF
Cardiff Oncology, Inc.
$1.72+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Cardiff Oncology, Inc. (CRDF) is a publicly traded company with 6 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 4 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 14 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | 2026-04-27 | Aggarwal Ajay | COO | Award | 400,000 | $1.72 | $688,000 | N/A | N/A |
| 2026-04-17 | 2026-04-06 | Muntner Joshua B | CFO | Award | 486,650 | $1.58 | $768,907 | N/A | N/A |
| 2026-04-16 | 2026-04-06 | Muntner Joshua B | CFO | Award | 486,650 | $1.58 | $768,907 | N/A | N/A |
| 2026-04-02 | 2026-03-31 | Mohindru Mani | CEO | Award | 600,000 | $1.62 | $972,000 | N/A | N/A |
| 2026-02-18 | 2026-02-13 | Lindsay Brigitte Ute | CAO | Award | 200,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-18 | 2026-02-17 | Mohindru Mani | CEO | Award | 200,000 | $0.00 | $0 | N/A | N/A |
| 2025-07-31 | 2025-07-30 | Pace Gary W | Director | Purchase | 15,000 | $2.45 | $36,750 | -0.4% | -14.3% |
| 2025-07-31 | 2025-07-30 | Pace Gary W | Director | Purchase | 275,000 | $2.45 | $673,750 | -0.4% | -14.3% |
| 2025-06-27 | 2025-06-26 | Armitage James O | Director | Award | 40,565 | $0.00 | $0 | N/A | N/A |
| 2025-06-27 | 2025-06-26 | Pace Gary W | Director | Award | 40,565 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.